Metabolomics of prostate cancer patients to identify diagnostic and prognostic biomarkers
Not Applicable
- Conditions
- Health Condition 1: C61- Malignant neoplasm of prostate
- Registration Number
- CTRI/2023/01/048921
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients aged >= 18 years
2) Prostate cancer Any T, any N, M0 or M1
Exclusion Criteria
1.Patients who are not willing to participate and will not provide signed informed consent
2.Patients with metabolic disorders
3.Thyrotoxicosis patients
4.Patients with uncontrolled DM, defined as HbA1c >=7.5%
5.Patients with hepatic dysfunction that is those in whom serum bilirubin will be more than 1.5 and, AST and ALT will be more than 2.5 fold higher than the upper limit of normal at baseline
6.Patients in whom serum creatinine will be more than 1.5 fold higher than the upper limit of normal
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method